An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 208799
Company: TEVA PHARM

Products on NDA 208799

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AIRDUO DIGIHALER	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.055MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Discontinued	None	Yes	No
AIRDUO DIGIHALER	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.113MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Discontinued	None	Yes	No
AIRDUO DIGIHALER	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.232MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Discontinued	None	Yes	No
AIRDUO RESPICLICK	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.055MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Prescription	None	Yes	No
AIRDUO RESPICLICK	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.113MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Prescription	None	Yes	No
AIRDUO RESPICLICK	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	0.232MG/INH;EQ 0.014MG BASE/INH	POWDER;INHALATION	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 208799

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/27/2017	ORIG-1	Approval	Type 4 - New Combination	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208799s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208799Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208799Orig1s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/16/2023	SUPPL-26	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208799Orig1s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208799Orig1s026ltr.pdf
07/09/2021	SUPPL-21	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208799s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208799Orig1s021ltr.pdf
01/27/2022	SUPPL-19	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208799Orig1s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208799Orig1s019ltr.pdf
02/21/2020	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208799s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208799Orig1s011ltr.pdf
12/20/2017	SUPPL-2	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208799s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208799Orig1s002ltr.pdf
03/02/2018	SUPPL-1	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208799s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208798Orig1s002,208799Orig1s001ltr.pdf

Labels for NDA 208799

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/16/2023	SUPPL-26	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208799Orig1s026lbl.pdf
01/27/2022	SUPPL-19	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208799Orig1s019lbl.pdf
07/09/2021	SUPPL-21	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208799s021lbl.pdf
02/21/2020	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208799s011lbl.pdf
03/02/2018	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208799s001lbl.pdf
12/20/2017	SUPPL-2	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208799s002lbl.pdf
01/27/2017	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208799s000lbl.pdf

Top